Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Uhh... you have a typo in your made-up chart: it's 2-73, not 2-72.
If the option writers (sellers) are the ones in control of the stock price, then I believe they still have time and ammo to return the price to below $5 (like they've done in the past). Any price above $5 and they have to give up their shares to the Call buyers. I don't know if this will play out this way, but it seems logical. Otherwise, the purpose for this retrace is to allow short sellers to cover and accumulate at a lower price.
We'll see what happens EOD...
Good work! You might be able to buy more around the same price or lower at the end of the day. We'll see...
They brought it down quickly to the $5 level. I believe they have every intention to hit it again late in the day to make the $5 Calls worthless. I'm waiting to load up at 3:55 with a market order.
If everyone who plans to buy more today would wait until after 3:50 and use market orders, we could likely break the cabal's back and mess up their plan.
Don't fall for this bounce at $5; the coordinated selling is not over yet. Wait until after 3:30 to load up.
Yeah, but I'd like to see the cabal get run over by huge demand today and close above $5, to crap on their plan.
Did you not see the wink emoji?
I'm hearing that the Alz P2/3 trial will be announced today at 3:30p.
It's very early in the day. I would not be adding here; I'm waiting until after 3:30p. I'm thinking about adding another 100k shares at market at 3:55 to see if I can help get the price above $5 at close.
And who says it's not a rigged collusive game?
I'll double check, but I believe filing an extension can delay your decision to re-characterize. The only downside is that if you choose not to recharacterize, then not only is the conversion tax due, if you hadn't paid in April, but also late penalty and interest.
The options writers don't want to lose their shares. I expect they'll take it to $4.9X by EOD.
Watch and learn, Grasshopper. The PPS will be below $5 today, if the manipulators succeed (would love to see a PR dropped at 3:30 today). Next week begins the climb higher; several announcements coming.
The price action of yesterday and today has nothing to do with the facts and results of the trial. We all know it's pure manipulation: coordinated profit taking and running stop-loss orders, which will ultimately drive the price down to make $5 Calls worthless. Loading time begins after 3:30p today.
Good for you! When I converted in Feb of 2016, I fully expected the PPS to be much higher by now; thought that results would overpower the shenanigans. I underestimated the persistence of the criminal cabal and its manipulation on small biotechs. However, I still believe we'll see at least $8 by April 12th. Many more announcements coming soon!
Converting to a Roth in 2016, means taxes are due by April 15th in 2017, if one doesn't recharacterize back to Traditional.
Would love to see a PR bomb dropped in the morning to f¤ck over the options sellers.
Don't worry, I've got this all figured out, whatever the PPS at the critical times.
I can read and understand tax laws just as well as a CPA.
You can only delay a tax payment, that's due in April, with late-fee penalty attached. But like I said, even with the penalty, one might still be dollars and shares ahead if the PPS is much higher by the Oct extension date.
I think you're doing a smart thing. I'm 60, so it makes sense for me as well, as the rules are a little more favorable for people over 59-1/2.
But really, everyone should consider this move, if they truly believe Anavex will be worth more than $3B in the future...even if they would have to pay additional income tax, the following year, on the converted shares sold to pay the conversion tax (by not waiting 5 years).
Yes, for 2016 tax year. I'm expecting the PPS to be at least $8 by April 15, but if not, I can either re-characterize some or all back to Traditional OR decide to file an extension AND delay my decision/pmt to Oct. Even if I have to pay a late-fee penalty, I should still be $$$$ ahead. That latter option just occurred to me thanks to an earlier post.
I did my conversion a year ago at $3.50...
I plan on paying the tax with both principle shares and converted shares. Yes, I'll have to pay some income tax (next year) on the converted shares, but will still be $$$$$ ahead.
Correct...
An extension doesn't allow one to delay any taxes due. If one stays with the conversion, the tax would have had to been paid in April, or a penalty would be applied. However, now that I think about it, even with paying the penalty, one might still be ahead share wise. Hmmm, something to ponder further, depending upon the PPS before April 15th.
It's not a matter of tax rate predictions; it's purely a matter of the total amount of tax payments over the remaining years of one's life. I'd rather pay a one-time conversion tax on, say, a $600k valuation than pay income taxes each year on withdraws and Required Minimum Distributions of 6%+ on $10M or more in a Traditional IRA. (assuming Anavex reaches a valuation of at least $4B, which shouldn't be a problem)
Yes, but if you decide to stay with the conversion, the tax pmt is still due by April 15th (18th this year), whether you extend the filing or not.
I did a conversion a year ago at $3.50 and will decide by April 13th whether I keep with it or re-characterize some or all back to Traditional. I'm 90% confident that I'll be able to keep with the conversion and gladly pay the big tax hit this year... my last tax payment!
Buying dips... smart move!
I think the next two days will be very interesting, between the sustained substantial volume and the $7.5 Call activity. Everyone grab your popcorn and take your seats.
There's no question 2-73 succeeds; the question is how much?
We're in good company! This will send a signal to the market!
Though I get your meaning, in no way are we the definition of "activist investors". That would be the likes of a Karl Icahn or Bill Ackman... ones who join boards to affect the direction of the company.
Now would be a good time to start forwarding Anavex information to Tom Price and other overseers of the NIH and Cares Act. What a wonderful opportunity for the first drug to be 2-73 and the resulting anticipated outcome! Feathers in caps all around!
FYI, I just sent a string of tweets to the NIH Director...
Francis S. Collins
@NIHDirector
Sent the same tweets to Tom Price...
Tom Price, M.D.
@SecPriceMD
Feel free to do the same!
Resting at 5.95, before the next leg higher...
AXON's stock price reaction speaks for itself. This is no surprise from a drug that has failed before... "In this interim analysis, these secondary endpoints did not demonstrate statistically significant differences for nelotanserin relative to placebo."
Agreed... I suspect savvy institutions, which normally don't invest in small biotech until P3, are getting in early due to the inevitability.
touché!